Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | ADA | P00813 | 4/20 | 0.34 |
| ▸ | PDE2A | O00408 | 3/20 | 0.34 |
| ▸ | MBOAT4 | Q96T53 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | PDE4A | P27815 | 1/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.34 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3130914 | 0.95 | SMN1; SMN2 (0.39) | SMN1; SMN2GAAHTTMEN1KMT2A | |
| SCHEMBL3130452 | 0.92 | SMN1; SMN2 (0.39) | SMN1; SMN2GAAHTTATMADA | |
| SCHEMBL5225877 | 0.81 | MBOAT4 (0.39) | SMN1; SMN2GAAHTTMBOAT4 | |
| SCHEMBL3130141 | 0.79 | GAA (0.45) | SMN1; SMN2GAAHTTATMMBOAT4 | |
| SCHEMBL5402153 | 0.79 | GAA (0.45) | SMN1; SMN2GAAHTTATMMBOAT4 | |
| SCHEMBL3133063 | 0.79 | GAA (0.45) | SMN1; SMN2GAAHTTATMMBOAT4 | |
| SCHEMBL5225541 | 0.76 | MBOAT4 (0.41) | MBOAT4 | |
| SCHEMBL3876315 | 0.76 | GAA (0.42) | SMN1; SMN2GAAHTTATMMBOAT4 | |
| SCHEMBL3868099 | 0.76 | GAA (0.42) | SMN1; SMN2GAAHTTATMMBOAT4 | |
| SCHEMBL3871870 | 0.76 | GAA (0.42) | SMN1; SMN2GAAHTTATMMBOAT4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1725560-B1 | 5,6-DIALKYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS | BASF SE (DE) | 2010-07-07 | — | — | EP | claimed |
| JP-2007527886-A | — | — | 2007-10-04 | — | — | JP | claimed |
| US-20070167463-A1 | 5,6-Dialkyl-7-aminotriazolopyrimidines, method for their production, their use for controlling pathogenic fungi, and agents containing said compounds | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-19 | — | — | US | claimed |
| EP-1725560-A1 | 5,6-DIALKYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-29 | — | — | EP | claimed |
| WO-2005087772-A1 | 5,6-DIALKYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167463-A1 | 5,6-Dialkyl-7-aminotriazolopyrimidines, method for their production, their use for controlling pathogenic fungi, and agents containing said compounds | DPM1, DCPS, DERA | SMN1; SMN2 3848/4885GAA 1276/4885HTT 3275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.